[ESPR] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 45.98%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 75,475 78,447 227,547 148,364 184,474 0 0 -
PBT -233,659 -269,108 -143,551 -97,165 -201,810 -166,988 -74,978 20.84%
Tax 54,158 49,716 22,638 11,857 2,875 2,132 1,672 78.49%
NP -287,817 -318,824 -166,189 -109,022 -201,810 -166,988 -74,978 25.11%
Tax Rate - - - - - - - -
Total Cost 363,292 397,271 393,736 257,386 386,284 166,988 74,978 30.06%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -381.34 -406.42 -73.04 -73.48 -109.40 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -4.33 -11.03 -6.05 -4.02 -7.54 -6.98 -3.33 4.47%
EPS Diluted -4.33 -11.03 -6.05 -4.02 -7.54 -6.98 -3.33 4.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.